title: The cellular and molecular basis of heart failure in regurgitant valvular diseases: the myocardial extracellular matrix as a building block for future therapy.
authors.affiliation: Division of Cardiovascular Pathophysiology, Department of Cardiothoracic Surgery and Howard Gilman Institute for Valvular Heart Diseases, Weill Medical College of Cornell University, New York, N.Y., USA.
authors.forename: Jeffrey S
authors.initials: JS
authors.lastname: Borer
authors.forename: Sharada L
authors.initials: SL
authors.lastname: Truter
authors.forename: Edmund McM
authors.initials: EM
authors.lastname: Herrold
authors.forename: Phyllis G
authors.initials: PG
authors.lastname: Supino
authors.forename: John N
authors.initials: JN
authors.lastname: Carter
authors.forename: Anuj
authors.initials: A
authors.lastname: Gupta
mesh_terms: D001022:Aortic Valve Insufficiency / Q000150:complications / Q000503:physiopathology / Q000628:therapy; D005109:Extracellular Matrix / Q000473:pathology; D005544:Forecasting; D006333:Heart Failure / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D006349:Heart Valve Diseases / Q000150:complications* / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D008944:Mitral Valve Insufficiency / Q000150:complications / Q000503:physiopathology / Q000628:therapy; D009206:Myocardium / Q000166:cytology / Q000473:pathology; D013318:Stroke Volume / Q000502:physiology; D016896:Treatment Outcome; D018487:Ventricular Dysfunction, Left / Q000150:complications / Q000503:physiopathology / Q000628:therapy